• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYHB2300668 盐酸伊立替康注射液 irinotecan hydrochloride Injection Chemical Drugs Supplementary Application 2023-11-21 Pfizer Australia Pty Ltd;Zydus Hospira Oncology Private Ltd view
CYHB1402580 盐酸伊立替康注射液 irinotecan hydrochloride Injection Chemical Drugs Supplementary Application 2014-07-21 上海创诺制药有限公司 Shanghai Acebright Pharmaceuticals Co Ltd Certificate Issued 2015-04-22 view
JYHB2001780 盐酸伊立替康注射液 irinotecan hydrochloride Injection Chemical Drugs Supplementary Application 2020-09-17 辉瑞投资有限公司 Pfizer Investment Co Ltd;Pfizer Australia Pty Ltd;Pfizer (Perth) Pty Ltd Certificate Issued 2020-11-20 view
CYHS1001262 盐酸伊立替康注射液 irinotecan hydrochloride Injection Chemical Drugs(6) Generic Drug 2011-04-27 江苏正大天晴药业股份有限公司 Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd Certificate Issued 2015-10-13 view
JYHB1900416 盐酸伊立替康注射液 irinotecan hydrochloride Injection Chemical Drugs Supplementary Application 2019-04-08 辉瑞投资有限公司 Pfizer Investment Co Ltd;Pfizer Australia Pty Ltd;Pfizer (Perth) Pty Ltd Certificate Issued 2019-06-10 view
JXHL0800359 盐酸伊立替康注射液 irinotecan hydrochloride Injection Chemical Drugs Import Drug Application 2008-11-05 Lemery SA De CV Certificate Issued 2011-02-14 view
CYHS1700567 盐酸伊立替康注射液 irinotecan hydrochloride Injection Chemical Drugs(4) Generic Drug 2018-07-02 四川汇宇制药有限公司 Sichuan Huiyu Pharmaceutical Co Ltd Certificate Issued 2021-03-30 view
CXL01213 盐酸伊立替康注射液 irinotecan hydrochloride Injection Chemical Drugs(5) New Drug Application 2001-05-11 安万特(中国)投资有限公司 Sanofi (China) Investment Co Ltd In Approval view
CYHS1501116 盐酸伊立替康注射液 irinotecan hydrochloride Injection Chemical Drugs(6) Generic Drug 2015-11-20 四川汇宇制药有限公司 Sichuan Huiyu Pharmaceutical Co Ltd Certificate Issued 2017-07-21 view
JYHB2002329 盐酸伊立替康注射液 irinotecan hydrochloride Injection Chemical Drugs(1) Supplementary Application 2020-11-18 辉瑞投资有限公司 Pfizer Investment Co Ltd;Pfizer Australia Pty Ltd;Pfizer (Perth) Pty Ltd Certificate Issued 2021-02-09 view
JXHL1200275 盐酸伊立替康注射液 irinotecan hydrochloride Injection Chemical Drugs Import Drug Application 2012-09-06 南光化学制药股份有限公司 Nang Kuang Pharmaceutical Co Ltd Certificate Issued 2017-03-29 view
CYHB2050199 盐酸伊立替康注射液 irinotecan hydrochloride Injection Chemical Drugs Supplementary Application 2020-04-14 海南锦瑞制药有限公司 Hainan Jinrui Pharmaceutical Co Ltd Certificate Issued 2021-07-16 view
JXHL0900407 盐酸伊立替康注射液 irinotecan hydrochloride Injection Chemical Drugs Import Drug Application 2009-12-25 韩美药品株式会社 Hanmi Pharm Co Ltd Certificate Issued 2010-12-09 view
JXHL0700122 盐酸伊立替康注射液 irinotecan hydrochloride Injection Chemical Drugs(3.1) Import Drug Application 2007-05-24 Cipla Ltd Cipla Ltd Certificate Issued 2009-12-16 view
JYHB1700726 盐酸伊立替康注射液 irinotecan hydrochloride Injection Chemical Drugs Supplementary Application 2017-05-23 辉瑞投资有限公司 Pfizer Investment Co Ltd;Pfizer Australia Pty Ltd;Pfizer (Perth) Pty Ltd Filed 2017-07-04 view
JYHB2300061 盐酸伊立替康注射液 irinotecan hydrochloride Injection Chemical Drugs Supplementary Application 2023-01-20 Pfizer Australia Pty Ltd;Pfizer (Perth) Pty Ltd view
CYHS1200575 盐酸伊立替康注射液 irinotecan hydrochloride Injection Chemical Drugs(6) Generic Drug 2013-04-25 浙江海正药业股份有限公司 Zhejiang Hisun Pharmaceutical Co Ltd Certificate Issued 2020-06-24 view
JXHS2000109 盐酸伊立替康注射液 irinotecan hydrochloride Injection Chemical Drugs(5.2) Import Drug Application 2020-07-06 Gland Pharma Limited Gland Pharma Ltd Certificate Issued 2021-03-31 view
CXHL1000615 盐酸伊立替康注射液 irinotecan hydrochloride Injection Chemical Drugs(3.4) New Drug Application 2011-02-16 齐鲁制药(海南)有限公司 Qilu Pharmaceutical (Hainan) Co Ltd Certificate Issued 2012-05-17 view
CYHB1850171 盐酸伊立替康注射液 irinotecan hydrochloride Injection Chemical Drugs Supplementary Application 2018-08-29 江苏恒瑞医药股份有限公司 Jiangsu Hengrui Pharmaceuticals Co Ltd Certificate Issued 2018-12-17 view